BioSpace News Archive

Marinus Pharmaceuticals, Inc. today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

MAIA Biotechnology, Inc. announced today that it has appointed Joseph F. McGuire as Chief Financial Officer. MAIA has also provided a corporate update announcing the creation of a wholly-owned subsidiary in Australia to execute on its global development strategy.

Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.59 billion for the third quarter ended July 31, 2021, an increase of 26% compared to the third quarter of 2020 and up 21% on a core(1) basis.

AnaptysBio, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved a second indication for GSK’s JEMPERLI (dostarlimab-gxly)

Dermata Therapeutics, Inc. (“Dermata” or the “Company”) (NASDAQ:DRMA, DRMAW), today announced the closing of its previously announced initial public offering of 2,571,428 shares of its common stock and accompanying warrants to purchase up to 2,571,428 shares of common stock.

GlaxoSmithKline (GSK) plc today announced the US Food and Drug Administration (FDA) approved a new indication for JEMPERLI (dostarlimab-gxly).

Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that Revive has entered into an exclusive license agreement (the “Agreement”) with Puerto Rico Science Technology and Research Trust (“PRSTRT”),

Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), today announced that phase 1b study results of IBI362, a glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor (GCGR) dual agonist, in Chinese participants with overweight or obesity have been published in EClinicalMedicine by the Lancet.

Alcon reported its financial results for the three and six months ended June 30, 2021.